Lactobacillus reuteri postbiotics improved growth performance and intestinal health of broilers with necrotic enteritis

罗伊氏乳杆菌后生元改善了患有坏死性肠炎的肉鸡的生长性能和肠道健康

阅读:2
作者:Mengjun Wu #,Yu Zha #,Yushu Xiong #,Yafei Zhang,Yu Zhang,Jiale Liu,Jiakun Yan,Peng Li,Changwu Li,Shuangshuang Guo

Abstract

Necrotic enteritis (NE) caused by coccidia and Clostridium perfringens (CCP) infection poses significant economic losses in poultry production. The present study aimed to identify the potential beneficial effects of Lactobacillus reuteri (LR) postbiotics on broilers under necrotic enteritis challenge. A total of 180 Arbor Acres+ broilers were randomly assigned to three groups: control group (CTR, fed basal diet), CCP group (challenged with CCP) and LR + CCP group (100 mg/kg LR with CCP infection). The formal animal experiment lasted for 28 days. The results showed that LR + CCP group exhibited higher body weight on days 19 and 28 compared with the CCP group, along with increased average daily feed intake and average daily gain during days 1-18, 19-28 and 1-28 (P < 0.05). The LR supplementation significantly reduced plasma diamine oxidase and lysozyme levels, increased jejunal villus height and ileal Claudin-1 and Mucin2 expression of NE-challenged broilers (P < 0.05). It down-regulated ileal IL-1β, IFN-γ, NOD1 and TGF-β expression and up-regulated jejunal MHC-II and ileal Leap2 expression of challenged broilers (P < 0.05). Furthermore, LR supplementation decreased ileal Firmicutes and Proteobacteria and increased Bacteroidota abundance (P < 0.05). In summary, dietary LR improved intestinal morphology, mitigated intestinal inflammation, and modulated ileal microbiota, contributing to the improvement of intestinal health and growth performance of NE-challenged broilers.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。